Wyeth Pharmaceuticals, a subsidiary of Pfizer, was charged with illegally marketing a drug that was not cleared for use by the FDA. A story in Reuters reports that Wyeth illegally marketed its organ transplant drug Rapamune for conditions it was not approved to treat.
The charges indicated that Wyeth trained and encouraged sales representatives to promote Rapamune for uses other than preventing rejection ...
continue reading...